| Insurance Industry | Financials Sector | Mr. Jukka Tapaninen M.Sc(Econ) CEO | XHEL Exchange | - ISIN |
| Finland Country | 78 Employees | - Last Dividend | - Last Split | - IPO Date |
Aiforia Technologies Oyj is a pioneering company that enhances the capabilities of pathologists and scientists working in preclinical and clinical laboratories across the globe. Utilizing advanced deep learning artificial intelligence (AI) software, Aiforia transforms image-based data into significant discoveries, decisions, and diagnoses. Operating out of Helsinki, Finland, since its inception in 2013, Aiforia caters to a diverse clientele, including pharmaceutical and biotechnology companies, contract research organizations (CROs), clinical laboratories, academic institutions, and other sectors in need of sophisticated image analysis solutions.
A platform designed for the development of AI models, Aiforia Create enables experts to automate the manual work stages associated with sample analysis in pathology. It offers standardization in analysis and aids in the identification of difficult-to-notice items, revolutionizing how scientists and pathologists process and analyze data.
This product brings AI-assisted diagnostics to the clinical pathology workflow, offering unprecedented support in the diagnostic process. Aiforia Clinical Suites empowers pathologists with high-tech tools to aid in faster and more accurate diagnoses, effectively enhancing the efficiency and reliability of clinical pathology services.
A cloud-based platform that serves as an educational tool for teachers in the fields of histology, anatomy, pathology, and related sciences. Aiforia Hub facilitates the teaching and learning process by providing access to advanced digital platforms, allowing for an immersive and interactive educational experience.
Tailored AI solutions that fit the specific needs of clients across different industries. These bespoke services allow organizations to leverage Aiforia's AI technology for their unique requirements, ensuring that they can benefit from the revolutionary potential of AI in their specific domain.